Preoperative positive urine cytology is a risk factor for subsequent development of bladder cancer after nephroureterectomy in patients with upper urinary tract urothelial carcinoma

World Journal of Urology

Volumn 30, Issue 2, 2012, Pages 271-275

  Kobayashi, Yasuyuki ^a   Saika, Takashi ^a   Miyaji, Yoshiyuki ^b   Saegusa, Michinao ^c   Arata, Ryoji ^d   Akebi, Naoki ^e   Takenaka, Tadasu ^f   Manabe, Daisuke ^g   Nasu, Yasutomo ^a   Kumon, Hiromi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c HIROSHIMA CITY HOSPITAL   (Japan)

^d National Hospital Organization   (Japan)

^e Tsuyama Chuo Hospital   (Japan)

^f Japanese Red Cross Okayama Hospital   (Japan)

^g KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Bladder recurrence; Nephroureterectomy; Upper urinary tract; Urothelial carcinoma

Indexed keywords

ADULT; AGED; BLADDER TUMOR; CARCINOMA; CYTODIAGNOSIS; CYTOLOGY; FEMALE; FOLLOW UP; HUMAN; KIDNEY TUMOR; MALE; MIDDLE AGED; NEPHRECTOMY; PATHOLOGY; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; TUMOR RECURRENCE; URETER; URETER TUMOR; URINE; UROLOGIC SURGERY; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CYTODIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; RETROSPECTIVE STUDIES; RISK FACTORS; URETER; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS; URINE; UROLOGIC SURGICAL PROCEDURES; UROTHELIUM;

EID: 84859440075     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0731-y     Document Type: Review

References (22)

1. Sakamoto N, Naito S, Kotoh S et al (1991) Recurrence of bladder tumors following surgery for transitional cell carcinoma of the upper urinary tract. Eur Urol 20: 136-139.
2. Batata MA, Whitmore WF, Hilaris BS, Tokita N, Grabstald H (1975) Primary carcinoma of the ureter: a prognostic study. Cancer 35: 1626-1632.
3. Mufti GR, Gove JR, Badenoch DF et al (1989) Transitional cell carcinoma of the renal pelvis and ureter. Br J Urol 63: 135-140.
4. Steffens J, Nagel R (1988) Tumours of the renal pelvis and ureter. Observations in 170 patients. Br J Urol 61: 277-283.
5. Huben RP, Mounzer AM, Murphy GP (1988) Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 62: 2016-2020.
6. Miyake H, Hara I, Kamidono S, Eto H (2004) Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns. J Urol 172: 1127-1129.
7. Habuchi T, Takahashi R, Yamada H, Kakehi Y, Sugiyama T, Yoshida O (1993) Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet 342: 1087-1088.
8. Hafner C, Knuechel R, Stoehr R, Hartmann A (2002) Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies. Int J Cancer 101: 1-6.
9. Hafner C, Knuechel R, Zanardo L et al (2001) Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract. Oncogene 20: 4910-4915.
10. Vriesema JL, Aben KK, Witjes JA, Kiemeney LA, Schalken JA (2001) Superficial and metachronous invasive bladder carcinomas are clonally related. Int J Cancer 93: 699-702.
11. Catto JW, Yates DR, Rehman I et al (2007) Behavior of urothelial carcinoma with respect to anatomical location. J Urol 177: 1715-1720.
12. Catto JW, Hartmann A, Stoehr R et al (2006) Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance. J Urol 175: 2323-2330.
13. Kirkali Z, Tuzel E (2003) Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 47: 155-169.
14. Palou J, Rodriguez-Rubio F, Huguet J et al (2005) Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor. J Urol 174: 859-861, discussion 61.
15. Azemar MD, Comperat E, Richard F, Cussenot O, Roupret M (2009) Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol 29: 130-136.
16. Koda S, Mita K, Shigeta M, Usui T (2007) Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery. Jpn J Clin Oncol 37: 296-301.
17. Mullerad M, Russo P, Golijanin D et al (2004) Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. J Urol 172: 2177-2181.
18. Matsui Y, Utsunomiya N, Ichioka K et al (2005) Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 65: 279-283.
19. Zigeuner RE, Hutterer G, Chromecki T, Rehak P, Langner C (2006) Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int 98: 1181-1186.
20. Terakawa T, Miyake H, Muramaki M, Takenaka A, Hara I, Fujisawa M (2008) Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Urology 71: 123-127.
21. Raman JD, Messer J, Sielatycki JA, Hollenbeak CS (2011) Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005. BJU Int 107: 1059-1064.
22. Wu WJ, Ke HL, Yang YH, Li CC, Chou YH, Huang CH (2010) Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy? J Urol 183: 56-61.